Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Arakoda Generic Name & Formulations
Legal Class
Rx
General Description
Tafenoquine 100mg; tabs.
Pharmacological Class
Aminoquinoline.
How Supplied
Tabs—16
Manufacturer
Generic Availability
NO
Arakoda Indications
Indications
Malaria prophylaxis.
Arakoda Dosage and Administration
Adult
Swallow whole. Take with food. ≥18yrs: initially 200mg once daily starting 3 days before travel, then 200mg once weekly starting 7 days after last loading dose while in endemic area, then 200mg taken once, 7 days after last maintenance dose.
Children
<18yrs: not established.
Arakoda Contraindications
Contraindications
G6PD deficiency or unknown status. Nursing mothers when infant is G6PD deficient or status unknown. History of or current psychotic disorders.
Arakoda Boxed Warnings
Not Applicable
Arakoda Warnings/Precautions
Warnings/Precautions
Must test for G6PD deficiency prior to initiation. Monitor for hemolysis; discontinue if occurs. NADH-dependent methemoglobin reductase deficiency; monitor and discontinue if signs of methemoglobinemia occur. Consider discontinuing if psychotic symptoms (eg, hallucinations, delusions, disorganized thinking/behavior) occur. Discontinue if hypersensitivity reactions occur. Renal or hepatic impairment: monitor. Exclude pregnancy status prior to initiation. Pregnancy: not recommended; if detected during therapy, discontinue and switch to alternatives. Advise females of reproductive potential to use effective contraception during and for 3 months after last dose. Nursing mothers: not recommended (during and for 3 months after last dose) in G6PD-deficient infant or status unknown.
Arakoda Pharmacokinetics
See Literature
Arakoda Interactions
Interactions
Avoid concomitant OCT2 and MATE substrates (eg, dofetilide, metformin); if unavoidable, monitor and consider dose reduction of substrate if needed.
Arakoda Adverse Reactions
Adverse Reactions
Headache, dizziness, back pain, diarrhea, nausea, vomiting, increased ALT, motion sickness, insomnia, depression, abnormal dreams, anxiety; hemolytic anemia, methemoglobinemia, psychiatric effects, hypersensitivity reactions.
Arakoda Clinical Trials
See Literature
Arakoda Note
Not Applicable
Arakoda Patient Counseling
See Literature
